• Announcements

    • Joelf

      Upgraded Sclero Forums!   05/18/2017

      Welcome to the Upgraded and Redesigned Sclero Forums!!   Our Forums are even better and more up to date than before.   Happy Posting to all our Members!!
Sign in to follow this  
Followers 0

The role of high-dose intravenous immunoglobulin (IVIg) in rheumatology

2 posts in this topic

The role of high-dose intravenous immunoglobulin (IVIg) in rheumatology. IVIG remains relatively safe compared with other immunosuppressive drugs. Headaches and fatigue are common side effects but fortunately the more severe problems such as aseptic meningitis, venous thromboembolism and acute renal failure remain rare. Prashantha M. Vaitla. Rheumatology. 02/23/10. (Also see: Medications)


This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.

Share this post

Link to post
Share on other sites


I found this article very encouraging! I've been on IVIg treatments for 6 years this month. I'm now up to one 3-day treatment every 8 to 10 weeks. Every time we've tried stopping the treatments, my muscle enzymes (CPK) and fatigue started increasing again. It's a very expensive procedure, but thank goodness for insurance. So far, they have approved every treatment (knock on wood :emoticon-bang-head: ) and since it's considered out patient, I don't even have a co-payment (once my deductible is met). My only side effect is a 24 hour migrane that starts 24 hours after the treatments are finished. I can set my clock by it.


I'm no a big fan of the 3 days being hooked up, but I always have lots to do between computer work, reading and just listening to music. The 3 days is well worth the energy it gives me and the way it has held my CTDs at bay.


Thanks for finding and posting this article!

Janey Willis

ISN Support Specialist

(Retired) ISN Assistant Webmaster

(Retired) ISN News Director

(Retired) ISN Technical Writer for Training Manuals

International Scleroderma Network (ISN)

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  
Followers 0